Literature DB >> 1375662

Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy.

H A Doll1, N A Black, K McPherson, A B Flood, G B Williams, J C Smith.   

Abstract

A total of 388 men undergoing transurethral resection of the prostate for benign prostatic hypertrophy during 1988 entered a prospective cohort study designed to examine the outcome of surgery during postoperative year 1. Self-administered questionnaires were completed preoperatively, and at 3, 6 and 12 months postoperatively. The surgeons completed 1 questionnaire shortly after surgery and another questionnaire 3, 6 or 12 months later. The mortality rate during the 12 months of followup was 2.8% (11 deaths). The surgeons reported perioperative complications in 14% of the patients and immediate postoperative complications, excluding urinary tract infections, in 17%. During the first 3 months postoperatively 38% of the patients reported incontinence and 25% had a urinary tract infection. Between 6 and 12 months postoperatively only 12% of the patients were troubled by either condition. The postoperative prevalence of impotence (24%) did not alter during followup and was similar to that reported preoperatively (22%). Of the patients 74% reported feeling better and 78% experienced a decrease in the overall level of symptoms postoperatively. The improvement in symptom levels was greatest in those with the most severe preoperative symptoms, and obstructive symptoms were alleviated slightly more than irritative symptoms.

Entities:  

Mesh:

Year:  1992        PMID: 1375662     DOI: 10.1016/s0022-5347(17)37628-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  33 in total

1.  Ascites following prostatectomy: a rare presentation of comorbid disease.

Authors:  Güven Aslan; Müjde Soytürk; Aykut Kefi; Ilhan Celebi; Hale Akpinar
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 2.  Optimizing radical prostatectomy for the early recovery of urinary continence.

Authors:  Harveer S Dev; Prasanna Sooriakumaran; Abhishek Srivastava; Ashutosh K Tewari
Journal:  Nat Rev Urol       Date:  2012-01-24       Impact factor: 14.432

3.  Effect of transurethral resection of the prostate based on the degree of obstruction seen in urodynamic study.

Authors:  Dong Suk Min; Hee Ju Cho; Jung Yoon Kang; Tag Keun Yoo; Jeong Man Cho
Journal:  Korean J Urol       Date:  2013-12-10

4.  Bladder-outlet obstruction--assessment of symptoms.

Authors:  J M Reynard; P Abrams
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

5.  Urodynamics and laser prostatectomy.

Authors:  A Cannon; M de Wildt; P H Abrams; J J de la Rosette
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

6.  Technique and results of interstitial laser coagulation.

Authors:  R Muschter; A Hofstetter
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

7.  Efficacy of a vaporization-resection of the prostate median lobe enlargement and vaporization of the prostate lateral lobe for benign prostatic hyperplasia using a 120-W GreenLight high-performance system laser: the effect on storage symptoms.

Authors:  Kang Sup Kim; Sae Woong Choi; Woong Jin Bae; Su Jin Kim; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Tae-Kon Hwang; Sae Woong Kim
Journal:  Lasers Med Sci       Date:  2015-04-02       Impact factor: 3.161

Review 8.  Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate.

Authors:  Soo Jeong Kim; Omar Al Hussein Alawamlh; Bilal Chughtai; Richard K Lee
Journal:  Curr Urol Rep       Date:  2018-08-20       Impact factor: 3.092

9.  Analysis of the factors causing bladder irritation after transurethral resection of the prostate.

Authors:  Tae Im Kim; Jae Mann Song; Hyun Chul Chung
Journal:  Korean J Urol       Date:  2010-10-21

10.  Transurethral resection of the prostate with a bipolar tissue management system compared to conventional monopolar resectoscope: one-year outcome.

Authors:  Chang-Jun Yoon; Ji-Yoon Kim; Ki-Hak Moon; Hee-Chang Jung; Tong-Choon Park
Journal:  Yonsei Med J       Date:  2006-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.